Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar LordDividend (37.97) Submitted: 5/4/2011 10:59:34 AM : Outperform Start Price: $48.69 VRX Score: +1.58

Who will the CEO target next?

Report this Post 1 Comment
Member Avatar LordDividend (37.97) Submitted: 5/4/2011 11:46:44 AM
Recs: 0

Yeh, who?

Featured Broker Partners


Advertisement